DanCann Pharma A/S: Pain specialist Tina Horsted and DanCann Pharma A/S in collaboration on ambitious patient project
COPENHAGEN, Denmark, September 12, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the Company has entered a collaboration with Horsted Institute ApS (“Horsted Institute”).MD and pain specialist Tina Horsted from Horsted Institute and DanCann Pharma have started an ambitious observational study, which aims to raise awareness of the potentially beneficial effects of treatment with medical cannabis. The study aims to supply further knowledge among general practitioners, who hesitate to prescribe